Intervention

Whole Body Cryotherapy

Whole Body Cryotherapy (WBC)

Brief exposure to extremely cold air (-110C to -140C) in a specialized chamber, proposed to reduce inflammation, accelerate recovery, and activate cold-shock proteins.

Editor approved

Summary Can whole-body cryotherapy help you live longer or recover faster? Show / hide ↓

Whole-body cryotherapy means spending 2 to 4 minutes in air cooled to about -110°C to -140°C. Small studies in athletes suggest it may briefly reduce muscle soreness and pain, but there is no evidence that it extends life or prevents disease. Animal studies suggest that cold-shock proteins, which help cells respond to cold, may protect the brain, but this has not been shown in humans using cryotherapy. The treatment can cause frostbite, cold burns, or oxygen-related suffocation in poorly managed nitrogen-cooled chambers, and deaths have occurred. Sessions usually cost $30 to $80, making it an expensive option with unproven longevity benefits.

What this means for you: Cryotherapy may offer short-term relief after exercise, but it has not been shown to help people live longer. The safety risks and cost make it difficult to justify for longevity.

weak evidence

Research snapshot Consumer wellness service. Not FDA-approved as medical treatment. Safety concerns documented. First small human trial with body composition and skin outcomes published 2026.

Updated 2026-09-27

Whole body cryotherapy delivers extreme cold exposure at -110C to -140C for 2-4 minutes. Two small 2026 human pilots (Aisenpreis N=19, Ptaszek N=12) measured body composition and skin outcomes but neither randomized. Cold-shock protein RBM3 remains unverified in humans. Evidence is strongest for short-term athletic recovery; longevity-specific claims still lack randomized clinical support.

Evidence tierTier 3, Mixed human evidence, mechanism plausible

Typical dose2-4 minute sessions at -110C to -140C, 1-3 times per week. Protective gear for hands, feet, and ears required. Sessions preceded by dry-off and warm-up.

SafetyRisk of frostbite, burns, or skin injury if protective gear is inadequate. Contraindicated in pregnancy, severe hypertension, cardiovascular disease, peripheral vascular disease, neuropathy, and cold-induced conditions. Fatalities reported from improper use of nitrogen-cooled chambers (oxygen displacement).

Categorycold therapy

Last verified2026-09-27

What it is

Whole body cryotherapy (WBC) involves brief exposure to extremely cold air (-110C to -140C) in a specialized chamber. Sessions last 2-4 minutes. Unlike cold water immersion (10-15C), WBC uses air cooled by electricity or liquid nitrogen to reach much lower temperatures.

How it works

The extreme cold triggers vasoconstriction followed by reactive vasodilation upon exiting the chamber. Norepinephrine levels increase 2-3x baseline. In animal models, cold exposure activates cold-shock proteins, particularly RBM3, which shows neuroprotective and synapse-preserving effects. Whether this translates to humans through WBC exposure is unconfirmed.

Evidence

Evidence is strongest for short-term muscle recovery and pain reduction in athletes. Multiple small RCTs support these effects. For longevity-specific outcomes, evidence is absent. No human studies have measured cold-shock protein activation, neuroprotection, or mortality outcomes with WBC. The gap between mechanistic plausibility (from animal cold exposure studies) and clinical evidence (from WBC specifically) remains wide.

Safety concerns

WBC carries real risks. Frostbite and cold burns can occur if protective gear for hands, feet, and ears is inadequate. Nitrogen-cooled chambers carry asphyxiation risk from oxygen displacement, and fatalities have been reported from improper operation. WBC is contraindicated in pregnancy, severe hypertension, cardiovascular disease, peripheral vascular disease, neuropathy, and cold-induced conditions. The FDA issued a consumer warning in 2016 noting the lack of evidence for medical claims and the potential risks.

Practical considerations

Commercial WBC sessions cost $30-80 per session. Typical protocols use 2-4 minute exposures 1-3 times per week. Home units are not widely available due to safety concerns. Compared to cold water immersion, WBC is more expensive but shorter in duration. The two approaches may activate different pathways, but head-to-head comparative data is limited.

Fatal incidents on record

October 2015: a 24-year-old employee at Rejuvenice in Nevada was found frozen inside a cryotherapy chamber after using the machine unassisted; police reports concluded she likely suffocated after being trapped for at least 10 hours. April 2025: a nitrogen leak from a cryochamber at a small sports centre in the 11th district of Paris killed a gym employee in her late 20s and hospitalised a client in her 30s in critical condition; Paris prosecutors opened an investigation. Nitrogen displaces oxygen; leaks in enclosed spaces can cause loss of consciousness before symptoms register. Facilities without oxygen monitors and clear evacuation protocols carry that risk regardless of session length.

Clinical outcome data: ankylosing spondylitis (2026 meta-analysis)

A systematic review with meta-analysis, published in the Journal of Integrative and Complementary Medicine in February 2026, pooled 5 studies with 310 ankylosing spondylitis patients 1. Protocols varied: -60 to -110 degrees C, sessions of 80 seconds to 3 minutes 1. Pooled results favoured whole-body cryotherapy as an adjunct: BASDAI disease activity improved (p<0.001), ASDAS improved (p=0.015), function measured by BASFI improved (p=0.006), and pain on a visual analogue scale improved (p=0.005) 1. CRP inflammation did not change (p=0.684) 1. Heterogeneity was low; tau-squared was estimated as zero 1. This is clinical symptom data in an inflammatory rheumatic disease, in patients also on standard drug therapy. It is not longevity data and not evidence for whole-body cryotherapy in healthy people.

References

Every numbered citation in this entry links here. Each reference links out to the primary source.